85.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$83.90
Offen:
$84.15
24-Stunden-Volumen:
3.99M
Relative Volume:
1.34
Marktkapitalisierung:
$40.70B
Einnahmen:
$5.83B
Nettoeinkommen (Verlust:
$261.52M
KGV:
158.04
EPS:
0.5422
Netto-Cashflow:
$1.32B
1W Leistung:
+10.24%
1M Leistung:
+14.41%
6M Leistung:
+25.08%
1J Leistung:
+43.85%
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
VTR
Ventas Inc
|
85.69 | 39.85B | 5.83B | 261.52M | 1.32B | 0.5422 |
|
WELL
Welltower Inc
|
207.88 | 137.84B | 9.90B | 967.82M | 1.88B | 1.3269 |
|
OHI
Omega Healthcare Investors Inc
|
46.78 | 13.43B | 1.08B | 448.00M | 779.91M | 1.61 |
|
DOC
Healthpeak Properties Inc
|
16.96 | 11.82B | 2.80B | -10.95M | 1.15B | -0.0564 |
|
AHR
American Healthcare Reit Inc
|
51.53 | 8.99B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Ventas, Welltower See Growth Amid Senior Housing Push - Law360
RBC Capital Keeps Their Buy Rating on Ventas (VTR) - The Globe and Mail
Citigroup Adjusts Ventas Price Target to $96 From $88, Maintains Buy Rating - marketscreener.com
Ventas, Inc. $VTR Shares Sold by Impax Asset Management Group plc - MarketBeat
Ventas outlines 13–17% SHOP NOI growth target for 2026 while expanding senior housing investments - MSN
Argus Research Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $88 - 富途牛牛
Gainers Report: What are the risks of holding Ventas IncPortfolio Value Report & Technical Buy Zone Confirmations - baoquankhu1.vn
Charter Senior Living Expands Portfolio with Management of Two Ventas Communities - Senior Living News
Ventas' Growth, Investments in Senior Housing May Lift Earnings, RBC Says - marketscreener.com
Ventas price target raised to $88 from $80 at Argus - TipRanks
Analysts’ Opinions Are Mixed on These Real Estate Stocks: Ventas (VTR) and Park Hotels & Resorts (PK) - The Globe and Mail
Ventas price target raised to $91 from $83 at RBC Capital - TipRanks
Ventas (VTR): KeyBanc Raises Price Target to $90 Following Overw - GuruFocus
KeyBanc raises Ventas stock price target to $90 on strong rent growth - Investing.com India
Ventas (NYSE:VTR) Price Target Raised to $90.00 - MarketBeat
RBC Raises Price Target on Ventas to $91 From $83, Keeps Outperform Rating - marketscreener.com
Argus Adjusts Price Target on Ventas to $88 From $80, Maintains Buy Rating - marketscreener.com
A Quick Look at Today's Ratings for Ventas Inc(VTR.US), With a Forecast Between $85 to $93 - 富途牛牛
KeyBanc Adjusts Price Target on Ventas to $90 From $85, Maintains Overweight Rating - marketscreener.com
RBC Thinks Ventas Can Keep Growing Senior Housing Fast - Finimize
Goldman Sachs Adjusts Price Target on Ventas to $100 From $94, Maintains Buy Rating - marketscreener.com
36 U.S. REITs Expected To Raise Dividends In Q1 2026 - Seeking Alpha
Ventas, Inc. (VTR) Reports Strong 2025 Growth, Accelerates Senior Housing Investments - Insider Monkey
BofA Securities Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $91 - 富途牛牛
Ventas Inc. Earnings Call Highlights SHOP-Driven Surge - TipRanks
Goldman Sachs REIT Stocks: Top 12 Stock Picks - Insider Monkey
Ventas stock price target raised to $100 by Goldman Sachs on acquisition momentum - Investing.com
Goldman Sachs Raises Ventas Price Target to $100 From $94 - marketscreener.com
Beyond The Numbers: 4 Analysts Discuss Ventas Stock - Benzinga
Cantor Fitzgerald Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $93 - 富途牛牛
Why Ventas (VTR) Is Up 6.6% After Dividend Hike And 2026 Earnings Guidance And What's Next - simplywall.st
UBS Adjusts Ventas Price Target to $85 From $82, Maintains Neutral Rating - marketscreener.com
Ventas amends ATM sales agreement, increases available common stock to $2.5 billion By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Overweight rating on Ventas stock at $93 By Investing.com - Investing.com South Africa
UBS Maintains Ventas Inc(VTR.US) With Hold Rating, Raises Target Price to $85 - 富途牛牛
Ventas amends ATM sales agreement, increases available common stock to $2.5 billion - Investing.com Nigeria
Cantor Fitzgerald reiterates Overweight rating on Ventas stock at $93 - Investing.com
Ventas Expands At-the-Market Equity Offering Capacity - TipRanks
Ventas' (VTR) Overweight Rating Reiterated at Cantor Fitzgerald - MarketBeat
Ventas, Inc. Amends ATM Sales Agreement - TradingView
Evercore ISI Adjusts Price Target on Ventas to $90 From $86, Maintains Outperform Rating - marketscreener.com
BMO Capital Adjusts Price Target on Ventas to $93 From $90, Maintains Outperform Rating - marketscreener.com
Evercore ISI raises Ventas stock price target to $90 on SHOP growth By Investing.com - Investing.com India
Evercore ISI raises Ventas stock price target to $90 on SHOP growth - Investing.com India
Diamond Hill Capital Management Inc. Sells 23,624 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas Inc. erweitert Aktienverkaufsprogramm auf 2,5 Milliarden US-Dollar - Longbridge
With $800 million in 2026 acquisitions so far, US senior living remains priority, Ventas CEO says - McKnight's Senior Living
Ventas (VTR) Is Up 6.3% After Dividend Hike And 2026 Guidance Update Has The Bull Case Changed? - Yahoo Finance
Signal Recap: What are the future prospects of Ventas IncWeekly Trading Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn
Ventas Results And Dividend Raise Highlight Senior Housing Growth Focus - Yahoo Finance
Ventas, Inc. $VTR Position Raised by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):